{"id":"https://openalex.org/W2222956135","doi":"https://doi.org/10.1017/cbo9780511712265.017","title":"Implications for research design and study implementation","display_name":"Implications for research design and study implementation","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W2222956135","doi":"https://doi.org/10.1017/cbo9780511712265.017","mag":"2222956135"},"language":"en","primary_location":{"id":"doi:10.1017/cbo9780511712265.017","doi":"https://doi.org/10.1017/cbo9780511712265.017","is_oa":false,"landing_page_url":"https://doi.org/10.1017/cbo9780511712265.017","pdf_url":null,"source":{"id":"https://openalex.org/S4306462995","display_name":"Cambridge University Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antipsychotic Trials in Schizophrenia","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W584357573","display_name":"Antipsychotic Trials in Schizophrenia"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023756758","display_name":"T. Scott Stroup","orcid":"https://orcid.org/0000-0002-3123-0672","observed_orcids":["https://orcid.org/0000-0002-3123-0672"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Scott Stroup","raw_affiliation_strings":["Columbia University, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University, New York","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075093461","display_name":"Jeffrey Alan Lieberman","orcid":"https://orcid.org/0000-0002-1899-1776","observed_orcids":["https://orcid.org/0000-0002-1899-1776"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Lieberman","raw_affiliation_strings":["Columbia University, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University, New York","institution_ids":["https://openalex.org/I78577930"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I78577930"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17226326,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"281","last_page":"287"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8539999723434448},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8410000205039978},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9829999804496765},{"id":"https://openalex.org/keywords/perphenazine","display_name":"perphenazine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/catie-trial","display_name":"CATIE trial","score":0.6819999814033508},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7670000195503235},{"id":"https://openalex.org/keywords/dystonia","display_name":"dystonia","score":0.7289999723434448},{"id":"https://openalex.org/keywords/parkinsonism","display_name":"parkinsonism","score":0.7710000276565552},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.8360000252723694},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":0.9089999794960022},{"id":"https://openalex.org/keywords/long-term-antipsychotic-treatment","display_name":"long-term antipsychotic treatment","score":0.8640000224113464}],"concepts":[{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.8934555649757385},{"id":"https://openalex.org/C2776743534","wikidata":"https://www.wikidata.org/wiki/Q423520","display_name":"Perphenazine","level":2,"score":0.8380807638168335},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.8038836717605591},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.7950432300567627},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7823997139930725},{"id":"https://openalex.org/C2780777758","wikidata":"https://www.wikidata.org/wiki/Q418050","display_name":"Sertindole","level":4,"score":0.6771204471588135},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.6593053340911865},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.6252356767654419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5547010898590088},{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.5120084881782532},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.43097251653671265},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.4266376793384552},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.40830719470977783},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4036242365837097},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.39192312955856323},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35405415296554565}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1017/cbo9780511712265.017","doi":"https://doi.org/10.1017/cbo9780511712265.017","is_oa":false,"landing_page_url":"https://doi.org/10.1017/cbo9780511712265.017","pdf_url":null,"source":{"id":"https://openalex.org/S4306462995","display_name":"Cambridge University Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antipsychotic Trials in Schizophrenia","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W2056470410","https://openalex.org/W2076273987","https://openalex.org/W2089843122","https://openalex.org/W2156039371"],"related_works":["https://openalex.org/W2196573549","https://openalex.org/W1967298722","https://openalex.org/W2064580795","https://openalex.org/W2058396682","https://openalex.org/W2050336194","https://openalex.org/W2417050448","https://openalex.org/W2287117140","https://openalex.org/W1947738970","https://openalex.org/W2002442062","https://openalex.org/W2149950019"],"abstract_inverted_index":{"This":[0],"chapter":[1],"summarizes":[2],"the":[3,6,32,61,82,106,128],"features":[4],"of":[5,10,21,35,53,63,81,120],"Clinical":[7],"Antipsychotic":[8],"Trials":[9],"Intervention":[11],"Effectiveness":[12],"(CATIE)":[13],"schizophrenia":[14,94],"trial":[15],"that":[16,101,110],"are":[17],"relevant":[18],"to":[19,30,134],"interpretation":[20],"extrapyramidal":[22],"side":[23],"effects":[24],"(EPS)":[25],"findings.":[26],"CATIE":[27,70,107],"was":[28,132],"designed":[29],"address":[31],"overall":[33,139],"effectiveness":[34,140],"second-generation":[36],"antipsychotic":[37,43,97],"(SGA)":[38],"versus":[39],"a":[40],"mid-potency":[41],"first-generation":[42],"drugs":[44],"(FGA),":[45],"perphenazine,":[46],"based":[47],"on":[48],"treatment":[49],"discontinuation.":[50],"Using":[51],"measures":[52,68,119],"dystonia,":[54],"Parkinsonism,":[55],"akathisia,":[56],"and":[57,66,87,123,146],"tardive":[58],"dyskinesia":[59],"(TD),":[60],"analysis":[62],"incidence":[64],"rates":[65],"continuous":[67],"from":[69,105],"shows":[71],"no":[72,113],"substantial":[73],"or":[74],"statistically":[75],"significant":[76,114],"differences":[77,115],"between":[78],"modest":[79],"doses":[80],"intermediate":[83],"potency":[84],"FGA":[85],"perphenazine":[86,131],"four":[88],"SGAs":[89],"in":[90,116,138],"patients":[91],"with":[92,142],"chronic":[93],"requiring":[95],"maintenance":[96],"treatment.":[98],"The":[99],"conclusion":[100],"must":[102],"be":[103,135],"drawn":[104],"study":[108],"is":[109],"there":[111],"were":[112],"primary":[117],"outcome":[118],"acute":[121],"EPS":[122],"TD":[124],"overall,":[125],"while":[126],"at":[127],"same":[129],"time":[130],"shown":[133],"not":[136],"different":[137],"compared":[141],"olanzapine,":[143],"risperidone,":[144],"quetiapine,":[145],"ziprasidone.":[147]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}